List of Certificates of Suitability (CEPs) for r1_cep_2016_314___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for R1-CEP 2016-314 - Rev 00 of Egis Pharmaceuticals Plc Budapest Hu

score 20 · Accepted Answer

Egis Pharmaceuticals Plc Budapest Hu, based in Hungary, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

One of their significant offerings is Carvedilol, Synthetic route B, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2016-314 - Rev 00

This Chemical Type CEP, issued on August 28, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1745 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for r1_cep_2016_314___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Egis Pharmaceuticals PLC

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

DIGITAL CONTENT

7 CORPORATE CONTENT #SupplierSpotlight

16 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

DEVELOPMENTS

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

KEY PRODUCTS

SERVICES

API Manufacturing

API & Drug Product Development

KEY SERVICES

INSPECTIONS & REGISTRATIONS

Filters

R1-CEP 2016-314 - Rev 00

Valid

Chemical

2023-08-28

1745

01

Looking for Certificates of Suitability (CEPs) for R1-CEP 2016-314 - Rev 00 of Egis Pharmaceuticals Plc Budapest Hu